Descripción

Network pharmacology analysis showing compound-target-disease interaction networks for Mahuang Fuzi Xixin Decoction, revealing potential therapeutic mechanisms and molecular targets relevant to allergic rhinitis.

Figure 2

Diagram

Source Paper

Identification of Active Compounds of Mahuang Fuzi Xixin Decoction and Their Mechanisms of Action by LC-MS/MS and Network Pharmacology.

Evidence-based complementary and alternative medicine : eCAM (2020)

PMID: 32565854

DOI: 10.1155/2020/3812180

Cite This Figure

![Figure 2: Network pharmacology analysis showing compound-target-disease interaction networks for Mahuang Fuzi Xixin Decoction, revealing potential therapeutic mechanisms and molecular targets relevant to allergic rhinitis.]()

> Source: Xiao Liang et al. "Identification of Active Compounds of Mahuang Fuzi Xixin Decoction and Their Mec." *Evidence-based complementary and alternative medicine : eCAM*, 2020. PMID: [32565854](https://pubmed.ncbi.nlm.nih.gov/32565854/)

<figure>
  <img src="" alt="Network pharmacology analysis showing compound-target-disease interaction networks for Mahuang Fuzi Xixin Decoction, revealing potential therapeutic mechanisms and molecular targets relevant to allergic rhinitis." />
  <figcaption>Figure 2. Network pharmacology analysis showing compound-target-disease interaction networks for Mahuang Fuzi Xixin Decoction, revealing potential therapeutic mechanisms and molecular targets relevant to allergic rhinitis.<br>  Source: Xiao Liang et al. "Identification of Active Compounds of Mahuang Fuzi Xixin Decoction and Their Mec." <em>Evidence-based complementary and alternative medicine : eCAM</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32565854/">32565854</a></figcaption>
</figure>

Evidencia relacionada

Quercetin para Allergic Rhinitis

Calificación C · 5 estudios